Back to search
Epilepsy, Partial Seizures
Clinical trial pipeline · Data from ClinicalTrials.gov
See which Epilepsy, Partial Seizures trials you may qualify forClinical trial pipeline · Data from ClinicalTrials.gov
See which Epilepsy, Partial Seizures trials you may qualify forThe purpose of this study is to determine whether BHV-7000 is effective in the treatment of refractory focal epilepsy.
Epilepsy is frequently associated with cognitive and attentional disorders. Several studies have pointed out that there are modifications of brain activity in r…
This study will evaluate the safety and tolerability of SPN-817 in adults with treatment resistant seizures
The purpose of this study is to determine whether BHV-7000 is effective in the treatment of refractory focal epilepsy.
This will be a prospective, pilot, open-label, two-arm, parallel-group, randomized study to evaluate the efficacy and safety of low-intensity focused ultrasound…
Background: Epilepsy affects about 1 percent of the U.S. population. Most people with epilepsy respond well to medicine, but some do not. Researchers want peop…
Epilepsy is a common disease affecting 0.5 to 1% of the general population. Epilepsies refractory to drug treatment lead to increased morbidity, mortality and h…
This is a clinical research study for an investigational drug called RAP-219 in adult participants with focal seizures. This study is being conducted to determi…
A study to determine if BHV- 7000 is safe and tolerable in adults with refractory focal onset epilepsy